Institutions / Barclays PLC / Activity
Activity — Barclays PLC
2,902 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2025 as of | New | 57630J403 Common stock | $0 | +1 | 1 0.00% of portfolio | low |
| Q2 2025 as of | New | HEPA Black Global 5 LLC Common Stock | $0 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 150837607 Common stock | $0 | +2 | 2 0.00% of portfolio | low |
| Q1 2023 as of | New | 731916144 Common stock | $0 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 48208F105 Common stock | $0 | +1 | 1 0.00% of portfolio | low |
| Q1 2024 as of | New | 46186M605 Common stock | $0 | +2 | 2 0.00% of portfolio | low |
| Q1 2025 as of | New | 18452H206 Common stock | $1 | +3 | 3 0.00% of portfolio | low |
| Q1 2025 as of | New | 825693302 Common stock | $1 | +3 | 3 0.00% of portfolio | low |
| Q1 2025 as of | New | JOB GEE Group Inc Common Stock | $1 | +3 | 3 0.00% of portfolio | low |
| Q1 2025 as of | New | 125525527 Common stock | $1 | +3 | 3 0.00% of portfolio | low |
| Q1 2025 as of | New | 054754858 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q1 2023 as of | New | G39462125 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q2 2024 as of | New | M53051112 Common stock | $1 | +50 | 50 0.00% of portfolio | low |
| Q4 2023 as of | New | 98955N108 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q2 2025 as of | New | 68617J100 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q2 2025 as of | New | Relmada Therapeutics, Inc. Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | Dolphin Entertainment, Inc. Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | CytomX Therapeutics, Inc. Common stock | $1 | +2 | 2 0.00% of portfolio | low |
| Q1 2025 as of | New | American Battery Technology Co Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | New | WWR Westwater Resources, Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | 18469P118 Common stock | $1 | +35 | 35 0.00% of portfolio | low |
| Q1 2025 as of | New | 89458T205 Common stock | $2 | +27 | 27 0.00% of portfolio | low |
| Q1 2025 as of | New | 09077B104 Common stock | $2 | +6 | 6 0.00% of portfolio | low |
| Q3 2025 as of | New | 87166L209 Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 042255109 Common stock | $2 | +2 | 2 0.00% of portfolio | low |
| Q1 2025 as of | New | Curis, Inc. Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | Minerva Neurosciences, Inc. Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | Spectral AI, Inc. Common stock | $2 | +2 | 2 0.00% of portfolio | low |
| Q1 2025 as of | New | 98138J404 Common stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | SHIM Shimmick Corp Common Stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 08178Q309 Common stock | $2 | +5 | 5 0.00% of portfolio | low |
| Q1 2025 as of | New | RFL Rafael Holdings, Inc. Common Stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | PROK Prokidney Corp. Common Stock | $2 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 08862L103 Common stock | $3 | +11 | 11 0.00% of portfolio | low |
| Q1 2025 as of | New | VTGN Vistagen Therapeutics, Inc. Common Stock | $3 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | New | 20678X403 Common stock | $3 | +2 | 2 0.00% of portfolio | low |
| Q1 2025 as of | New | ANVS Annovis Bio, Inc. Common Stock | $3 | +2 | 2 0.00% of portfolio | low |
| Q1 2023 as of | New | 89532E208 Common stock | $3 | +4 | 4 0.00% of portfolio | low |
| Q4 2025 as of | New | 88831L202 Common stock | $3 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | 185064102 Common stock | $3 | +4 | 4 0.00% of portfolio | low |
| Q1 2025 as of | New | 25461T105 Common stock | $3 | +4 | 4 0.00% of portfolio | low |
| Q1 2025 as of | New | VVOS Vivos Therapeutics, Inc. Common Stock | $3 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | 92854T118 Common stock | $3 | +100 | 100 0.00% of portfolio | low |
| Q1 2025 as of | New | GXAI Gaxos.ai Inc. Common Stock | $4 | +3 | 3 0.00% of portfolio | low |
| Q2 2023 as of | New | 12482W309 Common stock | $4 | +3 | 3 0.00% of portfolio | low |
| Q1 2025 as of | New | PZG Paramount Gold Nevada Corp. Common Stock | $4 | +12 | 12 0.00% of portfolio | low |
| Q1 2023 as of | New | 75915K309 Common stock | $4 | +5 | 5 0.00% of portfolio | low |
| Q3 2024 as of | New | 49876K111 Common stock | $4 | +100 | 100 0.00% of portfolio | low |
| Q3 2025 as of | New | VRCA Verrica Pharmaceuticals Inc. Common Stock | $4 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | VATE INNOVATE Corp. Common Stock | $4 | +1 | 1 0.00% of portfolio | low |